UB Paderborn / Katalog / Suche / in CDI

Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)

Annals of oncology, 2022-03, Vol.33 (3), p.259-275

2022

Volltextzugriff (PDF)

Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation

Bone marrow transplantation (Basingstoke), 2012-06, Vol.47 (6), p.770-790

2012

Volltextzugriff (PDF)

JACIE accreditation for blood and marrow transplantation: past, present and future directions of an international model for healthcare quality improvement

Bone marrow transplantation (Basingstoke), 2017-10, Vol.52 (10), p.1367-1371

2017

Volltextzugriff (PDF)

NEW HORIZONS ON STEM CELL CRYOPRESERVATION THROUGH THE ARTIFICIAL EYES OF CD 34+, USING MODERN FLOW CYTOMETRY TOOLS

Transfusion and apheresis science, 2020-06, Vol.59 (3), p.102785-102785, Article 102785

2020

Volltextzugriff (PDF)

Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners

Bone marrow transplantation (Basingstoke), 2017-11, Vol.52 (11), p.1495-1503

2017

Volltextzugriff (PDF)

Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years’ experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases

Haematologica (Roma), 2010-02, Vol.95 (2), p.284-292

2010

Volltextzugriff (PDF)

Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry

Lupus, 2013-03, Vol.22 (3), p.245-253

2013

Volltextzugriff (PDF)

Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with ‘aggressive’ multiple sclerosis

Multiple sclerosis, 2021-07, Vol.27 (8), p.1198-1204

2021

Volltextzugriff (PDF)

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009

Bone marrow transplantation (Basingstoke), 2010-02, Vol.45 (2), p.219-234

2010

Volltextzugriff (PDF)

Evidence of DMSO-Induced Protein Aggregation in Cells

The journal of physical chemistry. A, Molecules, spectroscopy, kinetics, environment, & general theory, 2016-07, Vol.120 (27), p.5065-5070

2016

Volltextzugriff (PDF)

Evaluating the clinical effectiveness of autologous haematopoietic stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison: an exploratory study from the Autoimmune Diseases Working Party (ADWP) of the European Society of Bone and Marrow Transplantation (EBMT)

Bone marrow transplantation (Basingstoke), 2020-07, Vol.55 (7), p.1473-1475

2020

Volltextzugriff (PDF)

Safety and efficacy of autologous hematopoietic stem‐cell transplantation following natalizumab discontinuation in aggressive multiple sclerosis

European journal of neurology, 2019-04, Vol.26 (4), p.624-630

2019

Volltextzugriff (PDF)

Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions

Clinical and experimental immunology, 2005-07, Vol.141 (1), p.1-9

2005

Volltextzugriff (PDF)

Manipulation, and cryopreservation of autologous peripheral blood stem cell products in Italy: A survey by GITMO, SIDEM and GIIMA societies

Transfusion and apheresis science, 2020-04, Vol.59 (2), p.102753-102753, Article 102753

2020

Volltextzugriff (PDF)

SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking

Bone marrow transplantation (Basingstoke), 2015-02, Vol.50 (2), p.173-180

2015

Volltextzugriff (PDF)

Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience

Multiple sclerosis, 2012-06, Vol.18 (6), p.835-842

2012

Volltextzugriff (PDF)

SARS-CoV-2 was already circulating in Italy, in early December 2019

European review for medical and pharmacological sciences, 2021-04, Vol.25 (8), p.3342

2021

Volltextzugriff (PDF)

A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper

Multiple sclerosis, 2012-06, Vol.18 (6), p.825-834

2012

Volltextzugriff (PDF)

Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life

Blood, 2005-03, Vol.105 (6), p.2601-2607

2005

Volltextzugriff (PDF)

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe

Bone marrow transplantation (Basingstoke), 2006-03, Vol.37 (5), p.439-449

2006

Volltextzugriff (PDF)

Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells

Journal of endocrinological investigation, 2007-10, Vol.30 (9), p.RC26-RC30

2007

Volltextzugriff (PDF)

P50 OVERALL SURVIVAL ADVANTAGE OF MONOCLONAL ANTIBODIES BASED‐TREATMENTS IN MULTIPLE MYELOMA PATIENTS RELAPSED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

HemaSphere, 2023-05, Vol.7 (S2), p.38-38

2023

Volltextzugriff (PDF)

Allogeneic hematopoietic SCT for patients with autoimmune diseases

Bone marrow transplantation (Basingstoke), 2009-07, Vol.44 (1), p.27-33

2009

Volltextzugriff (PDF)

Autologous hematopoietic stem cell transplantation for autoimmune diseases

Bone marrow transplantation (Basingstoke), 2005-05, Vol.35 (9), p.869-879

2005

Volltextzugriff (PDF)

P932: ON‐DEMAND PLERIXAFOR WITH CYCLOPHOSPHAMIDE AND G‐CSF FOR HEMATOPOIETIC STEM‐CELL MOBILIZATION IN MULTIPLE MYELOMA PATIENTS: FINAL RESULTS OF THE MOZOBL06877 STUDY

HemaSphere, 2022-06, Vol.6 (Suppl), p.822-823

2022

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)

Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation

JACIE accreditation for blood and marrow transplantation: past, present and future directions of an international model for healthcare quality improvement

NEW HORIZONS ON STEM CELL CRYOPRESERVATION THROUGH THE ARTIFICIAL EYES OF CD 34+, USING MODERN FLOW CYTOMETRY TOOLS

Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners

Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years’ experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases

Autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: data from the European Group for Blood and Marrow Transplantation registry

Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with ‘aggressive’ multiple sclerosis

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009

Evidence of DMSO-Induced Protein Aggregation in Cells

Safety and efficacy of autologous hematopoietic stem‐cell transplantation following natalizumab discontinuation in aggressive multiple sclerosis

Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions

Manipulation, and cryopreservation of autologous peripheral blood stem cell products in Italy: A survey by GITMO, SIDEM and GIIMA societies

SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking

Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience

SARS-CoV-2 was already circulating in Italy, in early December 2019

A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper

Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe

Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells

P50 OVERALL SURVIVAL ADVANTAGE OF MONOCLONAL ANTIBODIES BASED‐TREATMENTS IN MULTIPLE MYELOMA PATIENTS RELAPSED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION

Allogeneic hematopoietic SCT for patients with autoimmune diseases

Autologous hematopoietic stem cell transplantation for autoimmune diseases

P932: ON‐DEMAND PLERIXAFOR WITH CYCLOPHOSPHAMIDE AND G‐CSF FOR HEMATOPOIETIC STEM‐CELL MOBILIZATION IN MULTIPLE MYELOMA PATIENTS: FINAL RESULTS OF THE MOZOBL06877 STUDY

Suchergebnisse filtern